INTERPACE BIOSCIENCES, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Interpace Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Interpace Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $4K, unchanged year-over-year.
  • Interpace Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $17K, a 467% increase year-over-year.
  • Interpace Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $17K, a 41.4% decline from 2022.
  • Interpace Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $29K.
  • Interpace Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was -$705K, a 1430% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17K $4K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17K $4K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $17K $5K -$1K -16.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $18K $4K +$15K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3K $4K -$12K -75% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $15K $4K -$14K -77.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $29K $6K +$28K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1K -$11K +$703K +98.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$702K $16K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$702K $18K +$3K +20% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$705K -$22K -$33K -300% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$672K -$714K -$728K -5200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $56K $16K +$3K +23.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $53K $15K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $53K $11K +$58K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$5K $14K +$5K +55.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10K $13K +$8K +160% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$18K $15K +$10K +200% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$28K -$47K -$44K -1467% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 $16K $9K +$2K +28.6% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 $14K $5K -$3K -37.5% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 $17K $5K -$1K -16.7% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 $18K -$3K +$52K +94.5% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 -$34K $7K +$49K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$83K $8K +$309K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$392K $6K +$3K +100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$395K -$55K +$53K +49.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 -$448K -$42K -$215K -124% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$233K -$301K -$65K -27.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$168K $3K -$6K -66.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$162K -$108K +$12.6M +99.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$12.8M $173K +$353K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$13.1M -$236K -$59K -33.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$13.1M $9K +$82K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$13.1M -$12.7M -$7.48M -143% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$5.66M -$180K -$244K -381% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 -$5.41M -$177K -$242K -372% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$5.17M -$73K -$139K -211% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$5.03M -$5.23M -$5.21M -43442% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $183K $64K $0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $183K $65K +$1K +1.56% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $182K $66K +$2K +3.13% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $180K -$12K -$2K -20% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 $182K $64K -$10K -13.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $192K $64K +$1K +1.59% Apr 1, 2013 Jun 30, 2013 10-Q 2014-11-05
Q1 2013 $191K $64K -$17K -21% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-08-19
Q4 2012 $208K -$10K +$254K +96.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$46K $74K -$109K -59.6% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-09-30
Q2 2012 $63K $63K -$122K -65.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $185K $81K +$1.12M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$939K -$264K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 $183K +$112K +158% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $185K +$115K +164% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.04M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $71K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $70K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.